You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥石科技(300725.SZ):專注於為客户提供創新化學產品以及一體化研發與生產服務
格隆匯 05-09 16:44

格隆匯5月9日丨藥石科技(300725.SZ)在投資者互動平台表示,我公司是全球醫藥研發和製造領域一站式CRDMO供應商,專注於為客户提供創新化學產品以及一體化研發與生產服務。公司在行業中的優勢體現在多個方面:在藥物發現階段,公司科學驅動的設計策略確保分子砌塊的新穎性和多樣性,可幫助客户提高苗頭化合物和先導化合物的篩選和優化效率;對特定化學結構具有豐富的知識及經驗,可快速交付具有挑戰性的化合物;具備完善的合成、工藝開發和生產能力,穩定的原料供應管理,可持續供應從克級、公斤級到噸級的分子砌塊產品,支持新藥研發、開發至商業化需求。在藥物開發和生產階段:公司以分子砌塊為核心資源,拉通了從藥物發現、藥物開發到商業化,以及從分子砌塊、中間體、原料藥到製劑,直至申報註冊的兩個一體化協同解決方案;同時,基於分子砌塊領域積累的產品和化學技術能力,在中間體、工藝路線設計、供應鏈管理、生產成本優化等方面形成獨特優勢。詳細情況請參考公司《2023年年度報吿》第13頁“核心競爭力分析”。目前,公司各項業務有序推進,未受到美國生物安全法案的影響。我們將繼續加強中、美兩地團隊的服務能力建設,充分發揮各自的地域優勢和技術優勢,同時繼續積極尋求自建或併購產能的機會,加快海外產能佈局建設,提升供應鏈韌性,為全球客户提供優質、穩定的服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account